Dengue is a disease endemic to tropical countries such as India. In the past two years, cases of COVID-19 associated Mucormycosis have become a commonly encountered phenomenon. However, cases of dengue associated Mucormycosis have not found a significant mention in the literature yet. We, therefore, report two such cases in which Mucormycosis developed after recovery from Dengue fever and try to dig into the possible mechanism behind such an occurrence.
TantawichienTThisayakornU. Dengue neglected tropical diseases – South Asia. San Isidro - Buenos Aires: Springer International Publishing AG, 2017, pp. 329–348.
3.
RaoVUSArakeriGMadikeriG, et al.COVID-19 associated mucormycosis (CAM) in India: a formidable challenge. Br J Oral Maxillofac Surg2021; 59: 1095–1098.
4.
PopliHGuptaASinghV, et al.Are low serum vitamin D levels a risk factor for advent of COVID-19 associated rhinocerebral mucormycosis: a preliminary case control study. Indian J Otolaryngol Head Neck Surg2022; 74: 3529–3533.
5.
SinghalPRawatASharmaS, et al.Invasive fungal infections in dengue recovered patients: a new phenomenon in the COVID-19 era. Indian J Otolaryngol Head Neck Surg2022; 74: 3321–3326.
6.
SuzukiSKitazawaTOtaY, et al.Dengue hemorrhagic shock and disseminated candidiasis. Intern Med2007; 46: 1043–1046.
7.
MasyeniSSantosoMSWidyaningsihPD, et al.Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: experience from Indonesia. Int J Infect Dis2021; 102: 152–154.
8.
LustigYKelerSKolodnyR, et al.Potential antigenic cross-reactivity between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and dengue viruses. Clin Infect Dis2021; 73: e2444–e2449.
9.
TshetenTClementsACAGrayDJ, et al.Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review. BMC Infect Dis2021; 21: 729.
10.
VervaekePVermeireKLiekensS. Endothelial dysfunction in dengue virus pathology. Rev Med Virol2015; 25: 50–67.
11.
BasuAChaturvediUC. Vascular endothelium: the battlefield of dengue viruses. FEMS Immunol Med Microbiol2008; 53: 287–299.
12.
BaldinCIbrahimAS. Molecular mechanisms of mucormycosis-the bitter and the sweet. PLoS Pathog2017; 13: e1006408.
